Idarucizumab: What Should We Know?
Cortese F, Calculli G, Gesualdo M, Cecere A, Zito A, De Vito F, Carbonara R, Carbonara S, Cortese AM, Ciccone MM.
Cortese F, et al. Among authors: calculli g.
Curr Drug Targets. 2018;19(1):81-88. doi: 10.2174/1389450118666170925155943.
Curr Drug Targets. 2018.
PMID: 28950812
Review.